Direct Answer
Health care analytics companies sell data and software that help payers, providers and drugmakers measure cost, quality and outcomes. Revenue is typically subscription-based, with services tied to value-based care contracts.
Industry Overview
Health Care Analytics sits within the health care sector. The first numbers to compare across companies here are recurring revenue and retention, customer count by type and revenue per member or per bed. The outside forces that move them are listed under Primary Macro Drivers.
Key Industry Metrics
- Recurring revenue and retention: Subscription income that repeats and the share of customers kept. Strong retention suggests data and software are built into payer and provider workflows.
- Customer count by type: Number of customers split among health plans, providers and drugmakers. Different buyers have different budgets and sales cycles, so the mix shows where growth depends.
- Revenue per member or per bed: Income earned per insured member or hospital bed served, a unit measure of pricing. Rising values suggest customers are buying more modules or higher-priced data.
- Gross margin: Share of revenue left after data licensing, hosting and service delivery costs. Margins depend on how much revenue is software versus services tied to value-based contracts.
- Pipeline of new data assets: New datasets and analytical products under development or recently licensed. Fresh data expands what can be sold, but only matters if customers pay for it.
Primary Macro Drivers
- Value-based care and risk contracts: Contracts that put providers at financial risk for outcomes create demand for cost and quality measurement, which supports subscriptions and revenue per member or per bed.
- Payer cost-containment efforts: Insurers under pressure to hold down medical spending buy tools that find waste and high-risk members, which supports customer count among payers and renewal rates.
- Pharma demand for real-world data: Drugmakers pay for de-identified claims and records to study how drugs perform, so their demand supports licensed data revenue and new data assets.
- Artificial intelligence tooling: AI tools can speed up analysis and let vendors offer more per customer, which shows in net retention but also raises the pace of competing launches.
Major Risks
- Data access and privacy rules: Rules on who may hold and share patient data can restrict what is collected or sold, raising compliance cost and limiting data assets; watch regulatory disclosures.
- Long enterprise sales cycles: Buyers take many months to evaluate and approve analytics, so revenue lags spending on sales; watch bookings versus recognized revenue.
- Competition from large electronic health record vendors: Record system vendors bundle analytics with their core product at little extra cost, which can pressure pricing and retention; watch net retention and win rates.
- Customer concentration: A few large payers or health systems may account for much of the revenue, so one loss moves results; watch customer concentration in filings.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Defensive |
| Capital Intensity | Low |
| Regulatory Intensity | Low |
| Industry Maturity | Growth |
| Geographic Importance | U.S. |
Companies Associated with Health Care Analytics
The SEC's Standard Industrial Classification has no code that describes health care analytics as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.
| Company | SEC classification | Revenue | Growth | Net margin | Year |
|---|---|---|---|---|---|
| Iqvia Holdings Inc. | Services-Commercial Physical & Biological Research | $16.3 billion | 5.9% | 8.3% | FY 2025 |
| Evolent Health, Inc. | Services-Management Services | $1.9 billion | -26.6% | -30.9% | FY 2025 |
| Doximity, Inc. | Services-Computer Programming Services | $645 million | 13.1% | 30.4% | FY 2026 |
| Health Catalyst, Inc. | Services-Computer Programming, Data Processing, Etc. | $311 million | 1.5% | -57.2% | FY 2025 |
Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the company directory and the health care hub.
Where to Go Next
The Health Care Analytics guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Health Care Equipment & Supplies
- Genomics & Sequencing
- Health Care Payments Technology
- Generic Pharmaceuticals
- Health Care Providers & Services
- Gene Therapy
- Health Care Technology
- Gene Editing
Put it to work
Frequently Asked Questions
What are the main KPIs for the Health Care Analytics industry?
Key performance indicators for the Health Care Analytics industry include: Recurring revenue and retention, Customer count by type, Revenue per member or per bed, Gross margin, Pipeline of new data assets. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Health Care Analytics industry?
The Health Care Analytics industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.
What are the biggest risks in the Health Care Analytics industry?
The primary risks for Health Care Analytics companies include: Data access and privacy rules, Long enterprise sales cycles, Competition from large electronic health record vendors, Customer concentration. Investors should assess each company's exposure to these factors and its track record of navigating them.